中华皮肤科杂志 ›› 2005, Vol. 38 ›› Issue (1): 17-19.

• 论著 • 上一篇    下一篇

血清可溶性黏附分子与系统性红斑狼疮患者活动性的关系

周渭珩1, 程东庆2, 洪为松1, 徐瑾1, 许爱娥1   

  1. 1. 杭州市第三人民医院皮肤科, 310009;
    2. 浙江中医学院生命科学系
  • 收稿日期:2004-05-17 出版日期:2005-01-15 发布日期:2005-01-15
  • 基金资助:
    杭州市医药卫生科技基金资助项目(01A027)

Serum Soluble Adhesion Molecule and Its Relation with the Disease Activity in Systemic Lupus Erythematosus

ZHOU Wei-heng1, CHENG Dong-qing2, HONG Wei-song1, XU Jin1, XU Ai-e1   

  1. Department of Dermatology, Third Hospital, Hangzhou 310009, China
  • Received:2004-05-17 Online:2005-01-15 Published:2005-01-15

PDF

126

赞

摘要： 目的 探讨血清黏附分子中可溶性血管细胞黏附分子-1(sVCAM-1)和可溶性细胞间黏附分子-1(sICAM-1)水平与系统性红斑狼疮(SLE)活动性的关系。方法 sVCAM-1和sICAM-1检测采用酶联免疫吸附试验(ELISA)。结果 ①SLE患者血清sVCAM-1平均水平为2342.45ng/mL,显著高于正常对照组1239.68ng/mL(P<0.001);SLE患者血清sICAM-1平均水平为802.34ng/mL,显著高于正常对照组626.15ng/mL(P<0.001)。②SLE患者血清sVCAM-1水平和sICAM-1水平活动期均高于非活动期(P均<0.001),肾损组均高于非肾损组(P均<0.001)。③SLE组血清sVCAM-1和sICAM-1水平与SLE疾病活动指数(SLEDAI)、抗dsDNA抗体阳性呈正相关,与血清补体C3水平呈负相关。④糖皮质激素治疗后患者sVCAM-1水平和sICAM-1水平均低于治疗前(P均<0.001)。结论 sVCAM-1、sICAM-1可能参与SLE的发病,与SLE活动性相关。

关键词: 红斑狼疮,系统性, 血管细胞黏附分子-1, 胞间黏附分子1

Abstract: Objective To investigate the relationship between the serum level of soluble vascular cell adhesion molecule-1(sVCAM-1) and soluble intercellular adhesion molecule-1(sICAM-1) and the disease activity in systemic lupus erythematosus(SLE). Methods The serum concentrations of sVCAM-1 and sICAM-1 were measured by ELISA in 60 SLE patients and age- and sex-matched normal controls. Results ① Serum levels of sVCAM-1 and sICAM-1 were significantly increased in SLE patients compared with those in normal controls (P<0.001,both). ②Serum levels of sVCAM-1 and sICAM-1 were significantly higher in active SLE patients than those in inactive patients(P<0.001). And, serum levels of sVCAM-1 and sICAM-1 were significantly higher in the patients with proteinuria than those without proteinuria (P<0.001). ③Serum levels of sVCAM-1 and sICAM-1 were shown to have a negative correlation with serum level of C3 ; and a positive correlation with SLEDAI scores and serum level of anti-dsDNA. ④Serum levels of sVCAM-1 and sICAM-1 were higher before treatment than those after glucocorticoid treatment (P<0.05). Conclusions The results suggest that sVCAM-1 and sICAM-1 might play certain roles in the pathogenesis of SLE, and might be correlated with the disease activity.

Key words: Lupus erythematosus, systemic, Vascular cell adhesion molecule-1, Intercellular adhesion molecule-1